标题
cIAP2 as a therapeutic target in colorectal cancer and other malignancies
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 13, Issue 11, Pages 1333-1345
出版商
Informa Healthcare
发表日期
2009-10-01
DOI
10.1517/14728220903277256
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis
- (2015) Luc Friboulet et al. NEOPLASIA
- MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), Amplified on Chromosome 9, Collaborate with p53 Deficiency in Mouse Osteosarcoma Progression
- (2009) O. Ma et al. CANCER RESEARCH
- Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells
- (2009) Hideaki Karasawa et al. CANCER SCIENCE
- Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
- (2009) T. Satoh et al. CLINICAL CANCER RESEARCH
- Involvement of Human Organic Cation Transporter 1 in the Hepatic Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel, Small Molecule Survivin Suppressant
- (2009) M. Iwai et al. DRUG METABOLISM AND DISPOSITION
- Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers
- (2009) M Wasif Saif et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs
- (2009) Dan-Arin Silasi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Design, Synthesis, and Evaluation of Potent, Nonpeptidic Mimetics of Second Mitochondria-Derived Activator of Caspases
- (2009) Wei Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cytoprotective effects of IAPs revealed by a small molecule antagonist
- (2008) Stefanie Galbán et al. BIOCHEMICAL JOURNAL
- SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP
- (2008) J. Lu et al. CANCER RESEARCH
- Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells
- (2008) T. Minematsu et al. DRUG METABOLISM AND DISPOSITION
- Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol
- (2008) Chie Ishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Survivin Antisense Oligonucleotides Effectively Radiosensitize Colorectal Cancer Cells in Both Tissue Culture and Murine Xenograft Models
- (2008) Franz Rödel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Potent, Orally Bioavailable Diazabicyclic Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases
- (2008) Yuefeng Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- The RING Domain of cIAP1 Mediates the Degradation of RING-bearing Inhibitor of Apoptosis Proteins by Distinct Pathways
- (2008) Herman H. Cheung et al. MOLECULAR BIOLOGY OF THE CELL
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
- (2008) Mads Gyrd-Hansen et al. NATURE CELL BIOLOGY
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Both cIAP1 and cIAP2 regulate TNF -mediated NF- B activation
- (2008) D. J. Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started